This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Faure, S.
Right arrow Articles by Laurentie, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faure, S.
Right arrow Articles by Laurentie, M.
Agricola
Right arrow Articles by Faure, S.
Right arrow Articles by Laurentie, M.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, September 2009, p. 5523-5528, Vol. 75, No. 17
0099-2240/09/$08.00+0     doi:10.1128/AEM.00020-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Impact of Therapeutic Treatment with β-Lactam on Transfer of the blaCTX-M-9 Resistance Gene from Salmonella enterica Serovar Virchow to Escherichia coli in Gnotobiotic Rats{triangledown}

Stéphanie Faure, Agnès Perrin-Guyomard,* Jean-Michel Delmas, and Michel Laurentie

Laboratory for the Research and Investigation of Veterinary Drugs and Disinfectants, Pharmacokinetic-Pharmacodynamic Unit, AFSSA Fougeres, BP 90203, La Haute Marche, 35133 Javene, France

Received 6 January 2009/ Accepted 20 June 2009

The conjugative transfer of the plasmid carrying the blaCTX-M-9 gene from Salmonella enterica serovar Virchow isolated from a chicken farm to a recipient Escherichia coli strain was evaluated in vitro and in axenic rats inoculated with both strains, with or without selective pressure due to therapeutic doses of cefixime. The transfer of the blaCTX-M-9 gene of S. enterica serovar Virchow to E. coli was confirmed in vitro, at a low frequency of 5.9 x 10–8 transconjugants/donors. This transfer rate was higher in gnotobiotic rats and reached ~10–5 transconjugants/donors without selective pressure. This frequency was not affected by the addition of therapeutic doses of cefixime. Thus, estimates of in vitro transfer underestimated potential transfer in the digestive tract, and therapeutic doses of cefixime did not increase the selection for transconjugants.


* Corresponding author. Mailing address: Laboratory for the Research and Investigation of Veterinary Drugs and Disinfectants, Pharmacokinetic-Pharmacodynamic Unit, AFSSA Fougeres, BP 90203, La Haute Marche, 35133 Javene, France. Phone: 33(2) 99-94-78-78. Fax: 33(2) 99-94-78-80. E-mail: a.perrin-guyomard{at}afssa.fr

{triangledown} Published ahead of print on 6 July 2009.


Applied and Environmental Microbiology, September 2009, p. 5523-5528, Vol. 75, No. 17
0099-2240/09/$08.00+0     doi:10.1128/AEM.00020-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.